SG11202111521WA - Sustained-release microparticles containing deslorelin, and preparation method therefor - Google Patents
Sustained-release microparticles containing deslorelin, and preparation method thereforInfo
- Publication number
- SG11202111521WA SG11202111521WA SG11202111521WA SG11202111521WA SG11202111521WA SG 11202111521W A SG11202111521W A SG 11202111521WA SG 11202111521W A SG11202111521W A SG 11202111521WA SG 11202111521W A SG11202111521W A SG 11202111521WA SG 11202111521W A SG11202111521W A SG 11202111521WA
- Authority
- SG
- Singapore
- Prior art keywords
- sustained
- preparation
- method therefor
- microparticles containing
- release microparticles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020190050437A KR102249104B1 (en) | 2019-04-30 | 2019-04-30 | Sustained-release microspheres containing deslorelin and method of manufacturing thereof |
| PCT/KR2020/000657 WO2020222399A1 (en) | 2019-04-30 | 2020-01-14 | Sustained-release microparticles containing deslorelin, and preparation method therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202111521WA true SG11202111521WA (en) | 2021-11-29 |
Family
ID=73028838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202111521WA SG11202111521WA (en) | 2019-04-30 | 2020-01-14 | Sustained-release microparticles containing deslorelin, and preparation method therefor |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220202894A1 (en) |
| EP (1) | EP3949951A4 (en) |
| JP (1) | JP7253287B2 (en) |
| KR (1) | KR102249104B1 (en) |
| CN (1) | CN113747884A (en) |
| AU (1) | AU2020266058B2 (en) |
| BR (1) | BR112021021599A2 (en) |
| CA (1) | CA3137819C (en) |
| CL (1) | CL2021002761A1 (en) |
| IL (1) | IL287361A (en) |
| MX (1) | MX2021012923A (en) |
| PE (1) | PE20220491A1 (en) |
| SG (1) | SG11202111521WA (en) |
| WO (1) | WO2020222399A1 (en) |
| ZA (1) | ZA202108300B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230124229A (en) * | 2022-02-18 | 2023-08-25 | (주)인벤티지랩 | Sustained-release injectable compositions comprising deslorelin |
| WO2024003288A1 (en) * | 2022-06-30 | 2024-01-04 | Virbac | Deslorelin for attenuation of animal urine odor |
| WO2024003291A1 (en) * | 2022-06-30 | 2024-01-04 | Virbac | Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1045625A (en) * | 1996-04-30 | 1998-02-17 | Takeda Chem Ind Ltd | Pharmaceutical composition |
| CN1216636C (en) * | 1996-08-30 | 2005-08-31 | 派普泰克有限公司 | Titanium slow-release composition |
| JP4166590B2 (en) | 2003-02-04 | 2008-10-15 | 独立行政法人科学技術振興機構 | Double emulsion microcapsule generator |
| RS53890B1 (en) * | 2004-11-10 | 2015-08-31 | Tolmar Therapeutics, Inc. | A stabilized polymeric delivery system |
| MX2008009125A (en) * | 2006-01-18 | 2008-10-23 | Qps Llc | Pharmaceutical compositions with enhanced stability. |
| BRPI0902699A2 (en) | 2009-07-28 | 2011-04-12 | Marcelo Vivacqua | Chemical Method for Sexual Sterilization and Libido Elimination in Male Mammals |
| KR101583351B1 (en) * | 2014-11-28 | 2016-01-07 | 동국제약 주식회사 | Sustained-release microspheres enhancing removal rate of residual solvent and method of manufacturing thereof |
| CN105287390A (en) * | 2015-11-20 | 2016-02-03 | 北京博恩特药业有限公司 | Long-acting leuprorelin acetate microsphere and preparation method thereof |
| WO2017150824A1 (en) | 2016-03-03 | 2017-09-08 | 가천대학교 산학협력단 | Microneedle and manufacturing method therefor |
-
2019
- 2019-04-30 KR KR1020190050437A patent/KR102249104B1/en active IP Right Grant
-
2020
- 2020-01-14 EP EP20799171.2A patent/EP3949951A4/en active Pending
- 2020-01-14 PE PE2021001759A patent/PE20220491A1/en unknown
- 2020-01-14 CN CN202080031675.6A patent/CN113747884A/en active Pending
- 2020-01-14 CA CA3137819A patent/CA3137819C/en active Active
- 2020-01-14 BR BR112021021599A patent/BR112021021599A2/en unknown
- 2020-01-14 JP JP2021563253A patent/JP7253287B2/en active Active
- 2020-01-14 AU AU2020266058A patent/AU2020266058B2/en active Active
- 2020-01-14 WO PCT/KR2020/000657 patent/WO2020222399A1/en unknown
- 2020-01-14 SG SG11202111521WA patent/SG11202111521WA/en unknown
- 2020-01-14 US US17/605,185 patent/US20220202894A1/en active Pending
- 2020-01-14 MX MX2021012923A patent/MX2021012923A/en unknown
-
2021
- 2021-10-18 IL IL287361A patent/IL287361A/en unknown
- 2021-10-20 CL CL2021002761A patent/CL2021002761A1/en unknown
- 2021-10-27 ZA ZA2021/08300A patent/ZA202108300B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CL2021002761A1 (en) | 2022-06-03 |
| CN113747884A (en) | 2021-12-03 |
| MX2021012923A (en) | 2021-11-17 |
| CA3137819C (en) | 2024-01-09 |
| ZA202108300B (en) | 2023-01-25 |
| JP7253287B2 (en) | 2023-04-06 |
| IL287361A (en) | 2021-12-01 |
| US20220202894A1 (en) | 2022-06-30 |
| KR102249104B1 (en) | 2021-05-07 |
| WO2020222399A1 (en) | 2020-11-05 |
| EP3949951A4 (en) | 2023-01-18 |
| PE20220491A1 (en) | 2022-04-07 |
| JP2022530878A (en) | 2022-07-04 |
| CA3137819A1 (en) | 2020-11-05 |
| AU2020266058B2 (en) | 2023-04-06 |
| BR112021021599A2 (en) | 2021-12-21 |
| AU2020266058A1 (en) | 2021-11-18 |
| EP3949951A1 (en) | 2022-02-09 |
| KR20200126599A (en) | 2020-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202108300B (en) | Sustained-release microparticles containing deslorelin, and preparation method therefor | |
| EP3607940A4 (en) | Aripiprazole sustained-release microsphere and preparation method therefor | |
| SG11202007521PA (en) | Urea-substituted aromatic ring-linked dioxazoline compound, preparation method therefor, and uses thereof | |
| SG11202103677PA (en) | Low-halogen underfiller, preparation method therefor and application thereof | |
| ZA202001968B (en) | Tipping avoidance system and method | |
| SG11201913750TA (en) | System, method, and program for international trade | |
| ZA202107279B (en) | Catalytic-cracking catalyst and method for preparation thereof | |
| SG11202007554TA (en) | Dioxazoline compound, preparation method therefor, and uses thereof | |
| EP3590504A4 (en) | Sustained-release injection preparation containing donepezil and preparation method therefor | |
| EP3669864A4 (en) | Microparticles including finasteride, and method for producing same | |
| EP3733164A4 (en) | Microparticles comprising moxidectin, and preparation method therefor | |
| GB2584492B (en) | Method, garment and system | |
| ZA202107832B (en) | Pyrrole amidopyridone compound, preparation method therefor and use thereof | |
| EP3506612C0 (en) | Call recording system, call recording method, and call recording program | |
| IL282817A (en) | Novel compound, preparation method and application thereof | |
| EP3900705A4 (en) | Sustained-release injection comprising deslorelin, and preparation method therefor | |
| GB2586305B (en) | Catalyst preparation method | |
| PL3760633T3 (en) | Oxazino-quinazoline and oxazino-quinazoline type compound, preparation method therefor, and uses thereof | |
| EP3766494A4 (en) | Lenalidomide gastro-retentive sustained-release tablet and preparation method therefor | |
| EP3323429A4 (en) | Drug sustained-release carrier and method for producing same | |
| EP4071170A4 (en) | Pharmaceutical composition, preparation method therefor and use thereof | |
| GB2581814B (en) | Tessellatable container, system and method | |
| SG11202111393VA (en) | Reception system, reception method, and program | |
| SG11202103786WA (en) | Photocatalyst and preparation method therefor | |
| GB201908187D0 (en) | Method, garment and system |